Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Posted in Medical Device

September 30, 2019 • 2 min read

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive one-year results of its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial, successfully achieving both primary and secondary endpoints. Marianne Brodmann, M.D., Head of the Clinical Division of Angiology...